Shell Asset Management Co. raised its stake in HCA Healthcare Inc (NYSE:HCA) by 21.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 62,377 shares of the company’s stock after acquiring an additional 10,855 shares during the quarter. Shell Asset Management Co.’s holdings in HCA Healthcare were worth $5,479,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Bronfman E.L. Rothschild L.P. raised its holdings in shares of HCA Healthcare by 108.0% in the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 2,425 shares of the company’s stock worth $213,000 after acquiring an additional 1,259 shares during the last quarter. Kovack Advisors Inc. acquired a new position in shares of HCA Healthcare in the fourth quarter worth $234,000. Buckley Wealth Management LLC acquired a new position in shares of HCA Healthcare in the fourth quarter worth $264,000. Checchi Capital Advisers LLC acquired a new position in shares of HCA Healthcare in the fourth quarter worth $267,000. Finally, Massey Quick Simon & CO. LLC acquired a new position in shares of HCA Healthcare in the third quarter worth $251,000. 74.14% of the stock is owned by institutional investors.
In other HCA Healthcare news, insider Charles J. Hall sold 119,637 shares of the business’s stock in a transaction dated Wednesday, February 14th. The stock was sold at an average price of $100.14, for a total transaction of $11,980,449.18. Following the completion of the sale, the insider now owns 161,181 shares of the company’s stock, valued at $16,140,665.34. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Sandra L. Morgan sold 3,698 shares of the business’s stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $96.91, for a total value of $358,373.18. Following the sale, the senior vice president now directly owns 5,410 shares of the company’s stock, valued at approximately $524,283.10. The disclosure for this sale can be found here. In the last three months, insiders have sold 396,106 shares of company stock valued at $39,582,273. 2.90% of the stock is owned by company insiders.
HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, January 30th. The company reported $2.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.87 by $0.25. HCA Healthcare had a negative return on equity of 49.49% and a net margin of 4.89%. The firm had revenue of $11.56 billion during the quarter, compared to the consensus estimate of $11.19 billion. During the same quarter in the previous year, the business earned $1.80 earnings per share. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. equities research analysts forecast that HCA Healthcare Inc will post 8.71 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, March 30th. Shareholders of record on Thursday, March 1st will be given a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a yield of 1.39%. The ex-dividend date of this dividend is Wednesday, February 28th.
A number of research firms have recently weighed in on HCA. Argus set a $97.00 price target on HCA Healthcare and gave the stock a “buy” rating in a report on Wednesday, January 10th. Piper Jaffray Companies reissued a “hold” rating and issued a $101.00 price target on shares of HCA Healthcare in a report on Tuesday, January 30th. Sanford C. Bernstein reissued a “market perform” rating and issued a $116.00 price target (up from $105.00) on shares of HCA Healthcare in a report on Thursday, February 1st. ValuEngine raised HCA Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, November 30th. Finally, BMO Capital Markets boosted their price target on HCA Healthcare from $96.00 to $115.00 and gave the stock an “outperform” rating in a report on Thursday, February 1st. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $104.50.
About HCA Healthcare
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.